AFP and neoplasm: Previous studies have consistently demonstrated that compared to late recurrence, early recurrence exhibits more aggressive features, including higher serum AFP levels, larger tumor diameters, higher risk of extrahepatic spread, and a higher proportion with advanced stage, resulting in significantly worse post-recurrence survival (4, 6, 7).